Digital transformation (DT) is revolutionising healthcare. Propelled by the 'new normal'
associated with the COVID-19 pandemic, we have witnessed a surge in technology innovation
to assure continuity in care delivery.
In general terms, DT refers to the disruptive improvement process that introduces
changes in information management, computing, communication, and connectivity technologies
that impact organisational operations, structure, and business strategy.
However, managing clinical data flows and using advanced technologies are just part
of it. A common misconception about DT is that the disruption is merely technological;
instead, DT is a wider philosophical framework of business transformation propelled
by digital innovation to increase stakeholder satisfaction. Its aim goes beyond digitalising
the organisational environment - rather DT entails improving clinical governance by
leveraging the vast amount of data, supporting clinical decision-making, and ensuring
resource utilisation towards operational excellence.
In healthcare, operational excellence is correlated with the quality of care provided.
DT may boost quality-of-care and increase patient satisfaction by enhancing clinical
data communication and patient engagement.
Yet, in many countries, it is hard to move beyond concept and shift away from the
perception that digital transformation of health is only a technology-driven process
where “people merely have to adapt to a new normal" [1].
The Western Balkans are no exception. While the network infrastructure and digital
connectivity are still lagging behind the wider EU environment, some Balkan countries,
over the past several years, have made initial strides towards digitally transforming
healthcare, including state-of-the-art health information systems and open-source
telemedicine platforms [2]. However, the stagnating healthcare systems' groundwork
impedes a more significant innovation in care delivery; service provision is vertical
and siloed, resulting in excessive duplicated costs for low-quality disintegrated
care. Input-based fee-for-service models dominate, enabling healthcare providers to
declare most costs without reciprocity on quality-of-care performance. Consequently,
the higher healthcare expenditures do not yield matching trends in better health outcomes
jeopardising Sustainable Development Goals achievement [3]. The overall value proposition
is biased towards caregivers instead of the patients; patient feedback, perception,
satisfaction, and quality-of-life metrics are rarely accounted for in the policymaking
despite patients' increasing expectations for inclusion and meaningful participation
in the decision-making processes and initiatives that impact their health.
In short, value-based healthcare (VBHC) – defined as health outcomes achieved that
matter to patients relative to the cost of realising those outcomes [4] – is mostly
absent in the Balkans.
VBHC, a concept coined by Michael Porter [4], entails transforming health care systems
with the primary goal to maximise value to patients [4]. Determining "value" may require
a system-level model and framework to understand better the distributed components
that are interrelated by complex processes within a healthcare system [5].
The European Commission proposed a comprehensive meaning of “value” that expands beyond
the univariable interpretation based solely on monetary value in the context of cost-effectiveness.
The modified value definition encompasses four components [6]:
1.
Allocative "value": Equitable distribution of resources across all patient groups.
2.
Technical “value”: Achievement of best possible outcomes with available resources.
3.
Personal "value": Appropriate care to achieve patients' personal goals.
4.
Societal "value": Contribution of Healthcare to social participation and connectedness.
In the proposed VBHC value ratio, the numerator (health outcomes) specifies condition-specific
results most relevant to the patients, for example, improvement in functional independence
and quality of life. The denominator (costs) designates to cumulative spending across
the complete care delivery value chain.
DT may facilitate the transition towards VBHC, but it requires, among other, a top-down
cultural and behavioural change in clinical governance, management, and policymaking.
Regional providers, payers, and suppliers must acknowledge the current health system's
pitfalls and embrace DT to disrupt and shift the value-proposition favouring patients.
One of the critical prerequisites is for governments to install policies that incentivise
stakeholders who commit to transparent reporting of clinical outcome and patient-reported
outcome measures following the General Data Protection Regulation framework, and industry
data communication standards, such as Health Level-7 or Fast Healthcare Interoperability
Resources. In doing so, healthcare organisations would be able to assure safe bidirectional
communication between different system segments, a holistic approach to patient care
and better utilisation of resources for genuinely integrated patient-centred healthcare.
Tremendous resources will be needed to get the current health sector out of its 'comfort'
zone; DT may resolve many of its current limitations by disrupting the healthcare
governance to respond to the outdated healthcare systems in the Balkans.
The current pandemic has provided compelling evidence on the necessity of DT in healthcare
as a means to introduce VBHC.
In the effort to pave the way to VBHC in the region effectively, DT can offer ample
opportunities to increase process efficiency and establish sustainable, high-quality
patient-centric care [7], which is widely accessible [5].
By maximising leadership and clinical governance, one can assure relatively fast results.
Healthcare organisations are likely to experience steady growth of return on investments
as patients are drawn by evidence-based, universal, validated quality-of-care.
In addition, through DT, governments will be empowered for better resource utilisation
and thus deliver on their commitments to provide high-quality, high-value patient-centric
universal health coverage.
The benefits of that are multiple. If it is to be judged by similar experiences, this
will entail rewarding the local providers who deliver the VBHC on predefined global
quality metrics.
Universal health coverage by 2030 is an ambitious goal, and success requires a collective
approach to overcome technical, political and cultural challenges towards health equality.
The Balkan countries should embrace DT as a stepping stone towards VBHC leveraging
real-time data on clinical status; a robust interoperability infrastructure across
multiple healthcare organisations is key. Data-driven patient segmentation represents
a powerful tool to guide decision-making during the healthcare journey in terms of
medical services and therapies offered to patients and, importantly, on what terms
[8,9]. Personalised care based on patient profiles and multidisciplinary data analytics,
should accelerate the establishment of VBHC in the Balkans.
While DT must not be seen as a panacea for all vulnerabilities of the region's healthcare
systems, it should be regarded as the foundation of a future modernised healthcare
systems [10] and a pivotal initial step to facilitate the transition VBHC.
Embracing digital health innovation to map patient-reported outcomes will lead to
operational excellence in healthcare – it will also establish a transparent ecosystem
where all patients are adequately informed throughout their care pathway to achieve
better health outcomes.
Author Contributions
R.R. conceptualised the presented idea. R.R and N.M developed the theory and wrote
the manuscript with support from K.W. All authors discussed the findings and contributed
to the final manuscript.
Declaration of Interests
Dr Whaba has nothing to disclose. Dr Milevska-Kostova has nothing to disclose. Dr
Rosalia reports non-financial support from Zan Mitrev Clinic, outside the submitted
work